← Leaderboards
Russell P Pesavento
University Of Illinois At Chicago
$691,270
Attributed
$691,270
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $138.3K · FY2019–23$200K$150K$100K$50K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$691,270 · 1
By mechanism
K08$691,270 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Gabriella Anne Szewczyk$231,344
- Deepak Shukla$19,733,938
- Michael David Colvard$300,474
- Robert F Klie$2,956,733
- Aaron C Hinken$790,656
Others in their field
Other Emerging Leaders on “Absorption”
- Aina E. Cohen · Stanford University$10,909,501
- Anna Upton · Global Alliance For Tb Drug Development$10,496,979
- Deborah Bunin · Sri International$10,209,148
- Jay Evans · University Of Montana$9,566,206
- Christian Arthur Heidbreder · Indivior, Inc.$8,445,278
- Richard Joseph Johnson · Colorado Research Partners, Llc$6,102,731
Research focus
AbsorptionAbscessAffectAffinityAdsorptionAnimal ModelAntimicrobialAreaBacteriaBactericideAmmoniumBiologicalCaries PreventionCellsCell SurvivalCellular AssayCeriumCerium Oxide NanoparticleChemical ModelsChildChildhoodChronic DiseaseClinical ApplicationCost Effective
Grant awards (5)
Novel Biofilm Inhibitors of Oral Streptococci$138,254
K08 · FY2023 · DE · contact PI
Novel Biofilm Inhibitors of Oral Streptococci$138,254
K08 · FY2022 · DE · contact PI
Novel Biofilm Inhibitors of Oral Streptococci$138,254
K08 · FY2021 · DE · contact PI
Novel Biofilm Inhibitors of Oral Streptococci$138,254
K08 · FY2020 · DE · contact PI
Novel Biofilm Inhibitors of Oral Streptococci$138,254
K08 · FY2019 · DE · contact PI